Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Beam Therapeutics Inc. (BEAM) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Beam Therapeutics Inc. (BEAM), most recent 12 months reported: revenue $156.03M, net loss $85.43M, free cash flow -$372.77M. Latest balance sheet on file: liquid cash $1.15B, total debt $100.26M, net cash $1.05B. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Vir Biotechnology, Inc. · Vaxart, Inc. · REGENXBIO Inc. · IMMUNITYBIO, INC. · AGENUS INC · ATARA BIOTHERAPEUTICS, INC. · Autolus Therapeutics plc · GINKGO BIOWORKS HOLDINGS, INC.

Stock screener

Watchlist